Evaluation of safety, efficacy and durability of PDO thread lift- EVE & NU series (product of Meditronic Dongjun CO) for facial rejuvenation: An open label, phase 2, before- after, clinical trial.

Aftab Froozan Arya Organization0 个研究点目标入组 20 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•Male and female subjects 30-60 years old; willing to lift the face or eyebrow or improvement the nasolabial folds; providing written informed consent and attendance in follow up session. Exclusion criteria: History of any rejuvenated procedure during last years in face area; history of any Botulinum, laser, or intense pulsed light during last 6 month; history of Isotretinoin during last 3 month; collagen vascular disease; any systemic or topical disorders which interfere with process of wound healing; history of any implant in face area; severe cardiac disease or cardiac pacemaker; any active, chronic and recurrent infection; bleeding disorders, coagulopathy, any drugs affect bleeding time; susceptibility to keloids or scar formation; active smoker ( last 2 years); pregnancy/ breast feeding

发起方

Aftab Froozan Arya Organization